Recent News
Generic Drug Manufacturer Ranbaxy Pleads Guilty And Agrees To Pay $500 Million To Resolve False Claims Allegations Raised In Whistleblower Lawsuit
Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, pleaded guilty to charges relating to the manufacture and distribution of adulterated drugs made at two of its facilities. In addition to its guilty plea,...
Whistleblowers To Receive $2,839,219 For Exposing Violations Of Anti-Kickback Statute
In a settlement recently announced by the Department of Justice, Adventist Health System/West, d/b/a Adventist Health, and White Memorial Medical Center have agreed to pay the United States and the State of California $14.1 million to resolve allegations raised in a...
OIG Updates Provider Self-Disclosure Protocol
The Office of Inspector General (“OIG”) of the United States Department of Health and Human Services recently updated its Provider Self-Disclosure Protocol, which establishes a procedure for health providers to voluntarily disclose instances of potential fraud...
Amgen Inc. Agrees To Pay $24.9 Million To Resolve False Claims Act Lawsuit
Amgen Inc. has agreed to pay $24.9 million to resolve a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act. The allegations in this case relate to Amgen’s business practices concerning the sale of Aranesp, a pharmaceutical product. Based...
Office of Inspector General Issues Special Fraud Alert Addressing Physician Owned Entities
The Office of Inspector General for the Department of Health and Human Services (“OIG”) recently issued a Special Fraud Alert addressing physician-owned entities that derive revenue from the sale of implantable medical devices ordered by their physician-owners for use...
Whistleblower To Receive $200,000 For Exposing Improper Lobbying Practices
A former employee of Fluor Hanford LLC will receive $200,000 for filing a False Claims Act lawsuit that revealed Fluor’s improper use of federal funds for lobbying purposes. Fluor Hanford LLC, a Department of Energy (“DOE”) contractor, agreed to pay $1.1 million to...
Sales Representative To Receive $1,585,892.56 For Filing Whistleblower Lawsuit
A former sales representative will receive $1,585,892.56 as his share of the recovery obtained by the government in a False Claims Act lawsuit. CDW-Government LLC agreed to pay $5.66 million to resolve the whistleblower’s allegations in this case that it improperly...
Hospice Employee To Receive $1.8 Million For Blowing The Whistle On Medicare Fraud
A former employee of Hospice of Arizona L.C. will receive $1.8 million as a reward for filing a whistleblower lawsuit that exposed improper Medicare billing practices. To resolve allegations asserted in this False Claims Act case, Hospice of Arizona L.C., American...
Tennessee Whistleblower Awarded $405,000 For Exposing Fraudulent Rehabilitation Therapy Billing Practices
Nursing home manager Grace Healthcare LLC and its affiliate Grace Ancillary Services LLC have agreed to pay $2.7 million to resolve allegations that they submitted false claims to Medicare and TennCare for medically unreasonable and unnecessary rehabilitation...
Laboratory Research Product Contractor Agrees To Pay $5.65 Million To Resolve False Claims Act Lawsuit
Corning Incorporated has agreed to pay $5.65 million to resolve allegations that it knowingly presented false claims to the United States for laboratory research products. According to the claims raised in this whistleblower lawsuit, Corning failed to comply with its...
Sales Representative Receives $585,000 For Blowing The Whistle On CIA Contractor Kickback Scheme
A former sales representative is due to receive $585,000 for his role in filing a whistleblower lawsuit against American Systems Corporation, Anixter International Inc., and Corning Cable Systems LLC. This False Claims Act case included allegations that the defendants...
Whistleblowers Receive $4.4 Million For Exposing Pharmaceutical Company Fraud
In a settlement of False Claims Act lawsuits initiated by whistleblowers, Par Pharmaceutical Companies Inc. agreed to pay $45 million to resolve criminal and civil liability for improper marketing practices. The settlement resolves allegations that Par promoted the...